Form 4: Fulgent Genetics CFO Paul Kim Reports Routine Stock Dispositions for Tax Obligations
Insider Transaction Report
Fulgent Genetics, Inc. CFO and Treasurer Paul Kim reported the disposition of 1,837 shares of common stock across two transactions in late May 2025, primarily to satisfy tax withholding obligations related to vested restricted stock units.
Summary
- Paul Kim, the Chief Financial Officer and Treasurer of Fulgent Genetics, Inc. (FLGT), reported two dispositions of common stock.
- On May 23, 2025, Mr. Kim disposed of 671 shares of common stock at a price of $20.31 per share.
- On May 26, 2025, an additional 1,166 shares of common stock were disposed of, also at a price of $20.31 per share.
- Both dispositions, totaling 1,837 shares, were identified with transaction code 'F', indicating shares withheld to satisfy tax withholding obligations.
- These tax withholdings arose from the vesting of restricted stock units (RSUs) granted to Mr. Kim on February 23, 2023, and February 26, 2024.
- Following these transactions, Paul Kim beneficially owns 343,702 shares of Fulgent Genetics common stock directly.
Sentiment
Score: 5
Explanation: The filing reports routine insider transactions for tax withholding purposes, which are neutral events and do not reflect positively or negatively on the company's performance or outlook.
Positives
- N/A The reported transactions are routine dispositions for tax withholding purposes upon RSU vesting and do not indicate a positive operational or strategic development for the company.
Negatives
- N/A The reported transactions are routine dispositions for tax withholding purposes upon RSU vesting and do not indicate a negative operational or strategic development for the company.
Risks
- N/A This Form 4 filing does not disclose new risks to the company.
Future Outlook
N/A This document is an insider transaction report and does not provide forward-looking statements or guidance.
Industry Context
N/A This document reports an individual insider transaction and does not provide broader industry context.
Stakeholder Impact
- Minimal impact on shareholders as the transactions are routine tax-related dispositions of a small number of shares by an executive, not a significant sale for personal liquidity or a change in investment thesis.
Key Dates
| Date | Description |
|---|---|
| 2023-02-23 | Grant date of certain restricted stock units (RSUs) to Paul Kim, which later vested and led to tax withholding. |
| 2024-02-26 | Grant date of certain restricted stock units (RSUs) to Paul Kim, which later vested and led to tax withholding. |
| 2025-05-23 | Transaction date for the disposition of 671 shares of common stock by Paul Kim for tax withholding. |
| 2025-05-26 | Transaction date for the disposition of 1,166 shares of common stock by Paul Kim for tax withholding. |
| 2025-05-28 | Date the Form 4 filing was signed and submitted to the SEC. |
Keywords
Fulgent Genetics, FLGT, Paul Kim, Form 4, insider transaction, stock disposition, restricted stock units, RSU vesting, tax withholding, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.